Xylenes, drops 0.1% 10 ml

Acute respiratory diseases with rhinitis (runny nose) phenomena; Acute allergic rhinitis; Pollinosis; Sinusitis; Eustachyitis; Middle otitis (as part of combined therapy to reduce nasopharyngeal mucosa edema); Preparing the patient for diagnostic manipulations in the nasal passages.

Active ingredient

How to take, the dosage

Interaction

Special Instructions

The recommended doses should not be exceeded, especially in children and the elderly. Prolonged (more than 10 days) or excessive use of the drug may cause “ricochet” effect (rhinitis medica) and/or atrophy of the nasal mucosa. Patients with prolonged QT interval syndrome using xylometazoline may be at increased risk of developing serious ventricular arrhythmias. Benzalkonium chloride, which is part of the drug, may cause irritation of the nasal mucosa.

Influence on the ability to drive vehicles, machinery: The drug does not affect the ability to operate vehicles or equipment. When prolonged use in excess of the recommended doses we cannot exclude the possibility of its systemic effect. In such cases, caution should be exercised when driving vehicles or operating equipment.

Please read the full version of the instructions for medical use before using the drug. See the instructions for medical use for complete information.

Synopsis

Contraindications

Hypersensitivity to xylometazoline or any of the excipients of the drug; Arterial hypertension; Tachycardia; Severe atherosclerosis; Glaucoma; Hyperthyroidism; Atrophic rhinitis; Inflammatory skin diseases or mucosa of the vestibule; Surgical interventions on the meninges (in anamnesis); Condition after transsphenoidal pituitaryectomy; Pregnancy; Use of monoamine oxidase inhibitors (MAOIs) (including 14 days after their withdrawal); Use of tricyclic or tetracyclic antidepressants; Childhood under 2 years old (for 0.05% solution); Childhood under 6 years old (for 0.1% solution).

With caution: Diabetes mellitus; Severe cardiovascular disease (incl. Coronary heart disease, angina pectoris); Prostatic hyperplasia; Pheochromocytoma; Porphyria; Breastfeeding period; Hypersensitivity to adrenergic drugs, accompanied by insomnia, dizziness, arrhythmia, tremor, increased blood pressure; Patients with prolonged QT interval syndrome.

Side effects

Overdose

Similarities